San Diego, California, United States In 2001 was created CDIB BioScience Ventures, which is appeared as VC. The company was established in North America in United States. The main office of represented VC is situated in the San Diego.
Speaking about the real fund results, this VC is 12 percentage points less often commits exit comparing to other organizations. The increased amount of exits for fund were in 2008. The average startup value when the investment from CDIB BioScience Ventures is 10-50 millions dollars. The important activity for fund was in 2006. Opposing the other organizations, this CDIB BioScience Ventures works on 17 percentage points more the average amount of lead investments. The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 10 - 50 millions dollars.
Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. The fund has exact preference in some founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Accelight Networks, Elixir Pharmaceuticals, Epiphany. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Biotechnology, Therapeutics.
The overall number of key employees were 1.
The typical case for the fund is to invest in rounds with 7-8 participants. Despite the CDIB BioScience Ventures, startups are often financed by Venrock, ARCH Venture Partners, Polaris Partners. The meaningful sponsors for the fund in investment in the same round are Venrock, Montreux Equity Partners, Domain Associates. In the next rounds fund is usually obtained by Venrock, MPM Capital, ARCH Venture Partners.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Government of Karnataka - Elevate 2018 | - |
| Guangrun Chuangtou | China, Hangzhou, Zhejiang |
| JHD | - |
| Lakeside Capital | Dallas, Texas, United States |
| Lightyear Capital | Beijing, Beijing, China |
| LT Invest. | - |
| Muyi Touzi | China, Shanghai |
| Novitas Capital | Pennsylvania, United States, Wayne |
| Park City Angels | Park City, United States, Utah |
| PCG Holdings | - |
| Rifkin-Pottle Group | - |
| Shenzhenshi Tianhe Tongxin Touzi | China, Guangdong, Shenzhen |
| Summation Health Ventures | California, Long Beach, United States |
| Total | France, Ile-de-France, Paris |
| Tristone Capital | Houston, Texas, United States |
| WeltN24 | Berlin, Berlin, Germany |
| Western Ontario Cummunity Futures Development Corporation Association (WOCFDCA) | - |
| WLR China Energy Infrastructure Fund | - |
| Yuechan Guquan | China, Foshan, Guangdong |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Ocera Therapeutics | $35M | 20 Feb 2008 | Palo Alto, California, United States | ||
Epiphany | $36M | 16 Mar 2007 | San Francisco, California, United States | ||
Proprius Pharmaceuticals | $11M | 08 Jan 2007 | San Diego, California, United States | ||
Aprima Medical Software | $6M | 28 Dec 2006 | Texas, United States | ||
Xanthus Pharmaceuticals | $25M | 01 Dec 2006 | Cambridge, Massachusetts, United States | ||
Elixir Pharmaceuticals | $31M | 27 Nov 2006 | Cambridge, Massachusetts, United States | ||
Nanosys | $41M | 09 Nov 2005 | Milpitas, California, United States | ||
Cerexa Inc. | $50M | 23 Aug 2005 | New York, New York, United States | ||
Somaxon Pharmaceuticals | $65M | 06 Jun 2005 | Solana Beach, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Ocera Therapeutics | $35M | 20 Feb 2008 | Palo Alto, California, United States | ||
Epiphany | $36M | 16 Mar 2007 | San Francisco, California, United States | ||
Proprius Pharmaceuticals | $11M | 08 Jan 2007 | San Diego, California, United States | ||
Aprima Medical Software | $6M | 28 Dec 2006 | Texas, United States | ||
Xanthus Pharmaceuticals | $25M | 01 Dec 2006 | Cambridge, Massachusetts, United States | ||
Elixir Pharmaceuticals | $31M | 27 Nov 2006 | Cambridge, Massachusetts, United States | ||
Nanosys | $41M | 09 Nov 2005 | Milpitas, California, United States | ||
Cerexa Inc. | $50M | 23 Aug 2005 | New York, New York, United States | ||
Somaxon Pharmaceuticals | $65M | 06 Jun 2005 | Solana Beach, California, United States |
